High sustained virologic response rates in patients with chronic hepatitis C virus GT1, 2 or 3 infection following 16 weeks of MK-3682/grazoprevir/ruzasvir plus ribavirin after having failed 8 weeks of a triplet drug regimen (Part C of C-CREST-1 & 2)

Autor: Janice Wahl, S. Jin, N. Gendrano, Frank J. Dutko, H.-C. Huang, E.J. Gane, H. Liu, M. Su, Eliav Barr, R. Plank, Jesper Bach Hansen, Ziv Ben Ari, Alex Lund Laursen, J. Bourque, S. Pianko, Bach-Yen Nguyen, Joan R. Butterton, A. Grandhi, Lawrence Serfaty, D. Fernsler, Wendy W. Yeh

Publikováno v: Serfaty, L, Pianko, S, Ben Ari, Z, Laursen, A L, Hansen, J B, Gane, E J, Huang, H C, Jin, S, Bourque, J, Liu, H, Grandhi, A, Su, M, Gendrano, N, Fernsler, D, Dutko, F, Nguyen, B Y T, Wahl, J, Barr, E, Yeh, W, Plank, R & Butterton, J R 2017, ' High sustained virologic response rates in patients with chronic hepatitis C virus GT1, 2 or 3 infection following 16 weeks of MK-3682/grazoprevir/ruzasvir plus ribavirin after having failed 8 weeks of a triplet drug regimen (Part C of C-CREST-1 & 2) ', Journal of Hepatology, vol. 66, no. 1, THU-264, pp. S306-S307 . https://doi.org/10.1016/S0168-8278(17)30931-5

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16af9aa59068d74152dd9f0bbfeeb544
https://vbn.aau.dk/da/publications/d84eec5d-ca88-4ee9-920d-98fa12a2d61e

Grazoprevir plus peginterferon and ribavirin in treatment-naive patients with hepatitis C virus genotype 1 infection: a randomized trial

Autor: M, Lagging, A, Brown, P S, Mantry, A, Ramji, F, Weilert, J M, Vierling, A, Howe, I N, Gendrano, P, Hwang, B, Zhang, J, Wahl, M, Robertson, N, Mobashery

Publikováno v: Journal of viral hepatitis. 23(2)

Grazoprevir (MK-5172, MerckCo., Inc.) is a selective inhibitor of the hepatitis C virus (HCV) NS3/4a protease. The aim of this study was to evaluate the safety and efficacy of grazoprevir at doses of 25-100 mg/day in combination with peginterferon an

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::e58c3ea08ef7d44a7eec056db0ec4f3f
https://pubmed.ncbi.nlm.nih.gov/26353843

The International Index of Erectile Function (IIEF): a state-of-the-science review

Autor: Raymond C. Rosen, Joseph C. Cappelleri, N Gendrano

Publikováno v: International journal of impotence research. 14(4)

The International Index of Erectile Function (IIEF) is a widely used, multi-dimensional self-report instrument for the evaluation of male sexual function. It is has been recommended as a primary endpoint for clinical trials of erectile dysfunction (E

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f598311e1120581fc86a5e1c8c4070c4
https://pubmed.ncbi.nlm.nih.gov/12152111

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.